Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-24-018142
Filing Date
2024-04-25
Accepted
2024-04-25 16:02:22
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a.htm DEFA14A 14703
2 GRAPHIC a03zr9a_chromadexxnotice001.jpg GRAPHIC 202903
3 GRAPHIC a03zr9a_chromadexxnotice002.jpg GRAPHIC 146110
  Complete submission text file 0001628280-24-018142.txt   496722
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37752 | Film No.: 24876103
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)